1. Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes. (April 2014) Authors: Baker, D J; Atkinson, A M; Wilkinson, G P; Coope, G J; Charles, A D; Leighton, B Journal: British journal of pharmacology Issue: Volume 171:Number 7(2014:Apr.) Page Start: 1629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes. (April 2014) Authors: Baker, D J; Wilkinson, G P; Atkinson, A M; Jones, H B; Coghlan, M; Charles, A D; Leighton, B Journal: British journal of pharmacology Issue: Volume 171:Number 7(2014:Apr.) Page Start: 1642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Growth of Pakistani children in relation to the 1990 growth standards. Issue 5 (1st November 1997) Authors: Kelly, A M; Shaw, N J; Thomas, A M C; Pynsent, P B; Baker, D J Journal: Archives of disease in childhood Issue: Volume 77:Issue 5(1997) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Normality of single fibre electromyographic jitter: a new approach. Issue 4 (April 1987) Authors: Baker, D J; Cross, N L; Sedgwick, E M Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 50:Issue 4(1987) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Senescent Cells: A Novel Therapeutic Target for Aging and Age‐Related Diseases. Issue 1 (5th December 2012) Authors: Naylor, R M; Baker, D J; van Deursen, J M Journal: Clinical pharmacology & therapeutics Issue: Volume 93:Issue 1(2013) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗